Skip to main content
Clinical Trials/NCT03811184
NCT03811184
Unknown
Not Applicable

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

MemScreen1 site in 1 country400 target enrollmentJanuary 17, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cognitive Impairment
Sponsor
MemScreen
Enrollment
400
Locations
1
Primary Endpoint
Ability to detect patients with mild cognitive impairment.
Last Updated
6 years ago

Overview

Brief Summary

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions.

The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.

The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.

The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Detailed Description

Characteristics of MemScreen : * Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder. * The application is a self-test by the patient under the supervision of a doctor. * The doctor has an account to be able to pass the test to patients. * The tablet test is anonymous without the possibility to identify the patient.

Registry
clinicaltrials.gov
Start Date
January 17, 2019
End Date
June 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
MemScreen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Major patients followed in memory clinic.
  • Performing a neuropsychological assessment less than 6 months old.
  • No visual or motor deficiency impeding the use of a digital tablet.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Ability to detect patients with mild cognitive impairment.

Time Frame: through study completion, an average of 6 months

To evaluate the ability of MemScreen to discriminate patients with an objective memory disorder from a validated neuropsychological reference test: the free and cued selective reminding test.

Study Sites (1)

Loading locations...

Similar Trials